Record Breaking Vaccine Development
- At President Trump’s direction, the entire Federal government is working to get a safe, effective vaccine for coronavirus to the frontlines as soon as possible.
- The United States is working in record time to develop a vaccine.
- FAUCI: “Going into a Phase One trial within three months of getting the sequence is unquestionably the world indoor record. Nothing has ever gone that fast.”
- The Administration and scientific community are studying multiple promising candidates to ensure we can find an effective vaccine as quickly as possible.
- FAUCI: “There are at least eight candidate COVID-19 vaccines in clinical development. The NIH has been collaborating with a number of pharmaceutical companies at various stages of development.”
- FAUCI: “We have many candidates and hope to have multiple winners. In other words, it’s multiple shots on goal.”
Getting Therapeutics to Patients
- As we work to develop a vaccine, the Administration is also working to develop and distribute therapeutics to treat coronavirus patients in need.
- Recently, the President announced an emergency use authorization for Remdesivir, the result of a lightning speed process to get therapeutics to patients immediately.
- FDA COMMISSIONER DR. STEPHEN HAHN: “As the President just announced, we authorized Gilead’s application for Emergency Use Authorization for the use of remdesivir in hospitalized patients….This is lightning speed in terms of getting something approved, and from clinical trial to getting it authorized from the FDA, it’s been quite the speedy, but also effective, process.”
The Administration is working to quickly distribute the drug to areas in need and we continue to explore other therapeutics